Lu X - Search Results

1

MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma.

Lu X, Zhang Y, Xue J, Evert M, Calvisi D, Chen X, Wang X. Lu X, et al. Toxicol Sci. 2024 Sep 24:kfae126. doi: 10.1093/toxsci/kfae126. Online ahead of print. Toxicol Sci. 2024. PMID: 39316419

2

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma.

Liu X, Hu J, Song X, Utpatel K, Zhang Y, Wang P, Lu X, Zhang J, Xu M, Su T, Che L, Wang J, Evert M, Calvisi DF, Chen X. Liu X, et al. Among authors: lu x. Cancers (Basel). 2019 Jul 3;11(7):930. doi: 10.3390/cancers11070930. Cancers (Basel). 2019. PMID: 31277283 Free PMC article.

3

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies.

Lu X, Paliogiannis P, Calvisi DF, Chen X. Lu X, et al. Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):49-61. doi: 10.1002/hep.31310. Epub 2020 Dec 3. Hepatology. 2021. PMID: 32394479 Free PMC article. Review.

4

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma.

Shang R, Song X, Wang P, Zhou Y, Lu X, Wang J, Xu M, Chen X, Utpatel K, Che L, Liang B, Cigliano A, Evert M, Calvisi DF, Chen X. Shang R, et al. Among authors: lu x. Gut. 2021 Sep;70(9):1746-1757. doi: 10.1136/gutjnl-2020-320716. Epub 2020 Nov 3. Gut. 2021. PMID: 33144318 Free PMC article.

5

YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice.

Lu X, Peng B, Chen G, Pes MG, Ribback S, Ament C, Xu H, Pal R, Rodrigues PM, Banales JM, Evert M, Calvisi DF, Chen X, Fan B, Wang J. Lu X, et al. Am J Pathol. 2021 Sep;191(9):1651-1667. doi: 10.1016/j.ajpath.2021.05.017. Epub 2021 Jun 12. Am J Pathol. 2021. PMID: 34129844 Free PMC article.

6

Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.

Lu X, Deng S, Xu J, Green BL, Zhang H, Cui G, Zhou Y, Zhang Y, Xu H, Zhang F, Mao R, Zhong S, Cramer T, Evert M, Calvisi DF, He Y, Liu C, Chen X. Lu X, et al. J Clin Invest. 2023 Jun 1;133(11):e163291. doi: 10.1172/JCI163291. J Clin Invest. 2023. PMID: 37040183 Free PMC article.

7

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma.

Lu X, Green BL, Xie C, Liu C, Chen X. Lu X, et al. JHEP Rep. 2023 Mar 9;5(7):100723. doi: 10.1016/j.jhepr.2023.100723. eCollection 2023 Jul. JHEP Rep. 2023. PMID: 37229173 Free PMC article. Review.

8

Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma.

Deng S, Lu X, Wang X, Liang B, Xu H, Yang D, Cui G, Yonemura A, Paine H, Zhou Y, Zhang Y, Simile MM, Urigo F, Evert M, Calvisi DF, Green BL, Chen X. Deng S, et al. Among authors: lu x. Cell Death Dis. 2024 Jun 22;15(6):441. doi: 10.1038/s41419-024-06839-8. Cell Death Dis. 2024. PMID: 38909034 Free PMC article.

9

Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment.

Zhang H, Zhu K, Zhang R, Guo Y, Wang J, Liu C, Lu X, Zhou Z, Wu W, Zhang F, Song Z, Lin S, Yang C, Li X, Liu Y, Tang Q, Yu X, Xu L, Liu C. Zhang H, et al. Among authors: lu x. Hepatology. 2024 Jul 1;80(1):69-86. doi: 10.1097/HEP.0000000000000784. Epub 2024 Feb 20. Hepatology. 2024. PMID: 38377465

10

Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation.

Lu X, Zhu Q, Cai J, Yang Z, Gu G, Pang L, Su M, Zhang F, Lin H, Wu W, Xu L, Liu C. Lu X, et al. Cancer Immunol Immunother. 2024 Nov 11;74(1):18. doi: 10.1007/s00262-024-03853-9. Cancer Immunol Immunother. 2024. PMID: 39527136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,291 results

Search Page

Filters